Original Articles 2012-02-20

The Use of Herbal Medicine and Traditional Medicine Formulations (TMFs) for Hypertension at Traditional Medicine Hospital, Yangon

This study was done to determine the use of herbal medicines and Traditional Medicine Formulations (TMFs) for treating hypertension at Outpatients' Department (OPD) of Traditional Medicine Hospital, Yangon. This study was a cross-sectional, descriptive study in 140 hypertensive patients attending th

Original Articles 2020-09-11

Is Community Intervention Effective for Improving Maternal, Newborn and Child Health Care in Hard-to-Reach Areas of Chin State, Myanmar?

To tackle the maternal, newborn and child health (MNCH) care needs is a challenging situation in remote and hard-to-reach areas. Intervention activities focusing on strengthening community health care network through community participation and supporting Basic Health Staffs for MNCH ser

Original Articles 2020-09-14

Incidence of Snakebite in Four Townships of Yangon Region

The true incidence of snakebite in Myanmar is unknown. The current data are based on hospital returns to Ministry of Health and Sports and they are likely to be under-reported. A community-based survey is useful to know the current burden of snakebite and thus for planning and formulating str

Next Prev

Aims of MHSR Journal

• To serve as an important medium for the publication of original research in the field of medical science and health research, thus filling gaps in health knowledge for effective utilization of research findings
• To impart current medical knowledge and updated scientific information obtained from research to health professionals for better and appropriate health care management
• To disseminate recent basic, applied and social research findings among health personnel of different strata for enhancing worldwide health development

Archives   2023

Myanmar   Health   Sciences   Research   Journal

Volume   35,  Number   1-3

TITLE:   Assessment of Safety and Immunogenicity of BBIBP-CorV (Myancopharm) COVID-19 Vaccine as a Third Dose (Booster) among Workers of Pharmaceutical Factory (Insein) in Yangon, Myanmar
AUTHOR:   Mo Mo Win1#, Aung Kyaw Kyaw1#, Han Win1*, Thae Mg Mg1, Kyaw Lwin Show1, Wah Wah Aung1, Mu Mu Shwe1 Hlaing Myat Thu1 and Zaw Than Htun1
SOURCE:   Myanmar Health Sciences Research Journal, 2023; 35(1-3): 1-9
ABSTRACT:  

Vaccination is an important strategy to stop the pandemic situation of COVID-19 infection. This study was conducted to determine the
safety and immunogenicity of BBIBP-CorV (Myancopharm) as a third dose (booster) among factory workers in Yangon. A single group prospective cohort study was conducted in Pharmaceutical Factory (Insein), Yangon, 2022. A total of 306 workers who had received two doses of any kind of COVID-19 vaccine before 6 months of the screening were enrolled. Adverse Events (AEs) were assessed and recorded by phone interviewing using Kobo Collect software. Safety hematological and biochemical parameters were also assessed. Immunogenicity was assessed by antibody (Ab) to SARS-CoV-2 spike antigen by Enzyme Linked Fluorescent Assay (VIDAS® SARS-COV-2 IgG assay, Biomerieux, France). Among 306 participants, the mean age was 45.8±8.1 years and male to female ratio was 1:2.73. During the seven days after vaccination, solicited local and systematic AEs were reported by 46(47.7%) and 97(31.7%) participants, respectively.